Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
P35998
UPID:
PRS7_HUMAN
Alternative names:
26S proteasome AAA-ATPase subunit RPT1; Proteasome 26S subunit ATPase 2
Alternative UPACC:
P35998; A4D0Q1; B7Z5E2; Q3LIA5; Q9UDI3
Background:
The 26S proteasome, featuring the ATPase subunit RPT1, plays a pivotal role in cellular protein homeostasis. As a component of this multiprotein complex, it is crucial for the ATP-dependent degradation of ubiquitinated proteins, facilitating the removal of misfolded or damaged proteins and those no longer needed. This process is essential for various cellular processes including cell cycle progression, apoptosis, and DNA damage repair.
Therapeutic significance:
Understanding the role of 26S proteasome regulatory subunit 7 could open doors to potential therapeutic strategies.